NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 8.759
EU - Europa 4.789
AS - Asia 3.843
SA - Sud America 480
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 69
OC - Oceania 4
Totale 18.080
Nazione #
US - Stati Uniti d'America 8.515
IT - Italia 1.918
GB - Regno Unito 1.130
CN - Cina 1.123
SG - Singapore 1.081
SE - Svezia 452
HK - Hong Kong 383
BR - Brasile 367
VN - Vietnam 345
DE - Germania 299
BD - Bangladesh 232
TR - Turchia 229
UA - Ucraina 188
FI - Finlandia 179
FR - Francia 157
CA - Canada 131
RU - Federazione Russa 127
KR - Corea 119
IN - India 99
NL - Olanda 70
BG - Bulgaria 64
AR - Argentina 45
MX - Messico 45
ID - Indonesia 34
PL - Polonia 28
IQ - Iraq 27
IE - Irlanda 25
ES - Italia 23
IR - Iran 22
LT - Lituania 20
CO - Colombia 18
CR - Costa Rica 18
IL - Israele 18
PK - Pakistan 18
BE - Belgio 17
ZA - Sudafrica 17
JM - Giamaica 16
JP - Giappone 15
SA - Arabia Saudita 15
CH - Svizzera 14
AE - Emirati Arabi Uniti 13
AT - Austria 13
EU - Europa 12
EC - Ecuador 11
SI - Slovenia 11
CL - Cile 10
MA - Marocco 10
EG - Egitto 9
MY - Malesia 9
TH - Thailandia 9
VE - Venezuela 9
DZ - Algeria 8
JO - Giordania 7
PY - Paraguay 7
UZ - Uzbekistan 7
BY - Bielorussia 6
DK - Danimarca 6
GT - Guatemala 6
CZ - Repubblica Ceca 5
GR - Grecia 5
HN - Honduras 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
GE - Georgia 4
KZ - Kazakistan 4
NI - Nicaragua 4
PA - Panama 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
KG - Kirghizistan 2
LV - Lettonia 2
MG - Madagascar 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
Totale 17.940
Città #
Ashburn 1.426
Santa Clara 844
Southend 832
Singapore 730
Woodbridge 496
Fairfield 433
Chandler 429
San Jose 383
Hong Kong 374
Jacksonville 356
Hefei 332
Houston 268
Ann Arbor 260
Beijing 246
Nyköping 246
Dearborn 234
Council Bluffs 218
Wilmington 200
Milan 185
Seattle 178
Rome 165
London 159
Dallas 152
Cambridge 150
Los Angeles 135
Izmir 120
Seoul 117
Helsinki 114
New York 106
Buffalo 89
Ho Chi Minh City 89
The Dalles 87
São Paulo 85
Naples 78
Hanoi 77
Princeton 70
San Diego 65
Chicago 64
Sofia 62
Eugene 61
Frankfurt am Main 57
Modena 57
Lauterbourg 54
Shanghai 51
Toronto 49
Des Moines 39
Moscow 37
Bari 36
Bologna 36
Munich 36
Florence 33
Palermo 33
Atlanta 28
Columbus 26
Philadelphia 26
Orem 25
Da Nang 24
Turin 24
Brescia 23
Catania 23
Chennai 23
Guangzhou 21
Dublin 20
Montreal 19
Mexico City 18
Phoenix 17
Boardman 16
Brooklyn 16
Brussels 16
Elk Grove Village 16
Haiphong 16
Redwood City 16
Salt Lake City 16
Memphis 15
San Mateo 15
Augusta 14
Ottawa 14
Stockholm 14
Vancouver 14
Warsaw 14
Amsterdam 13
Baghdad 13
Falkenstein 13
Jakarta 13
Mumbai 13
Norwalk 13
Rio de Janeiro 13
Kent 12
Manassas 12
Nanjing 12
San José 12
Tampa 12
Denver 11
Genoa 11
Parma 11
Tokyo 11
Verona 11
Boston 10
Falls Church 10
Johannesburg 10
Totale 11.998
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.961
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 385
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 380
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 366
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 331
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 327
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 326
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 325
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 319
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 316
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 314
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 311
Detectable HIV viral load is associated with metabolic syndrome 311
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 310
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 309
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 303
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 302
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 289
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 289
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 285
Severity of lipodystrophy is associated with decreased health-related quality of life 284
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 283
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 283
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 270
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 268
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 267
Age-related comorbidities in people living with HIV 266
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 264
Prevalence and risk factors of pubic lipomas in HIV-infected patients 263
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 259
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 256
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 255
How do frailty mediate pathway leading to disability 250
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 248
Virologic failure and metabolic syndrome in patients with HIV infection 248
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 248
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 240
Does lipodistrophy affect quality of life? 239
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 238
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 237
Body Image perception in HIV infected women with body fat redistribution. 236
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 222
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 219
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 215
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 213
È possibile un counselling HIV su internet? 212
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 211
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 209
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 209
Lipodystrophy and quality of life: a prospective study 206
Validity of body image perception in women with HIV. 204
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 203
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 200
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 199
Virologic failure and metabolic syndrome in patients with HIV infection 195
Relapse of HIV-related buffalo hump after liposuction 192
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 188
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 186
Qual è il rapporto tra qualità di vita e lipodistrofia 182
HIV counselling looks for new target and methods web versus face to face counselling 174
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 164
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 161
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 158
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 152
HIV counselling and prevention on the WEB 145
Totale 18.080
Categoria #
all - tutte 59.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022745 0 0 0 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/20265.021 335 235 509 561 579 402 507 273 544 428 360 288
2026/20271.994 174 326 543 951 0 0 0 0 0 0 0 0
Totale 18.080